Furthermore, neural stem cell transplantation (NSC) is emerging as a promising therapy for AD, primarily operating through the regulation of neuroplasticity through BDNF, while also reducing neuroinflammation and the aggregation of tau and Aβ [73]. This evidence concerns the gene MAPT and Alzheimer disease.